Signal Genetics Company

Signal Genetics, Inc., is a commercial-stage, molecular diagnostics company providing innovative diagnostic services.
Signal Genetics, Inc., is a commercial-stage, molecular diagnostics company providing innovative diagnostic services that help physicians make better-informed decisions concerning the care of their patients suffering from cancer.
The company was founded in April 2010 after becoming the exclusive licensee to the world-renowned research on multiple myeloma performed at the University of Arkansas for Medical Sciences (UAMS). More than 30 years of clinical research on nearly 10,000 multiple myeloma patients who received their care at UAMS went into the development of Signal Genetics’ flagship product, MyPRS® (Myeloma Prognostic Risk Signature).

Investors

Technology: Personalized Diagnostics
Headquarters: Carlsbad
Investment Stage: N/A
Number Of Exists: N/A
Founded Date: 2010
Industry: Precision Medicine
Employee Number: 51-100
Investor Type: N/A
Funding Status: M&A
Register and Claim Ownership